R

Rocket Pharmaceuticals
D

RCKT

2.92000
USD
0.04
(1.39%)
مغلق
حجم التداول
70,675
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
314,594,723
أصول ذات صلة
AAPL
AAPL
1.070
(0.50%)
213.420 USD
AMZN
AMZN
3.150
(1.43%)
223.060 USD
BA
BA
3.940
(1.86%)
215.760 USD
GOOG
GOOG
0.545
(0.30%)
180.320 USD
LMT
LMT
0.15
(0.03%)
462.70 USD
MSFT
MSFT
7.08
(1.44%)
498.10 USD
NOC
NOC
4.22
(0.85%)
503.11 USD
S
SPCE
0.00000
(0.00%)
2.82000 USD
TSLA
TSLA
-1.95
(-0.62%)
313.73 USD
المزيد
الأخبار المقالات

العنوان: Rocket Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.